Vital Signs - Life Sciences and Drug Discovery Technologies Market Consolidation - Unique Aims of Mergers & Acquisitions

Vital Signs - Life Sciences and Drug Discovery Technologies Market Consolidation - Unique Aims of Mergers & Acquisitions

 

RELEASE DATE
09-Apr-2007
REGION
North America
Research Code: 9561-00-2E-00-00
SKU: HC00478-NA-MR_03950
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00478-NA-MR_03950
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on April 9, 2007, provides a strategic overview of the impact of consolidation in the life sciences and drug discovery technologies market. Additionally, an emerging company profile is provided for Network Biosystems, a developer of DNA analysis technologies for forensics, clinical diagnostics, homeland security, and genomic sequencing applications. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of March 26 - March 30, 2007.

Table of Contents

This week's issue:

Related Research
This issue of Vital Signs, released on April 9, 2007, provides a strategic overview of the impact of consolidation in the life sciences and drug discovery technologies market. Additionally, an emerging company profile is provided for Network Biosystems, a developer of DNA analysis technologies for forensics, clinical diagnostics, homeland security, and genomic sequencing applications. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of March 26 - March 30, 2007.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-2E-00-00
Is Prebook No